DOI: 10.1055/s-00032260

Digestive Disease Interventions

References

Liu L, Mayes PA, Eastman S. et al.
The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4.

Clin Cancer Res 2015;
21 (07) 1639-1651

Download Bibliographical Data

Access:
Access: